Industry Updates for the Psychedelics World | Page 7 of 35

Psychedelics News

Industry

18 Jul 2023

First Salts And Polymorphs of 4-OH-DiPT Discovered by Terran Biosciences; Patent Application Filed

A PCT patent application from Terran Biosciences was just published covering their discovery of novel salts and polymorphs of the compound 4-OH-DiPT....

By Microdose NewsDesk

Industry

14 Jul 2023

Legal Psychedelics: Which Compounds Will Be Approved Next?

Which psychedelics will be next to be FDA approved? We take a closer look....

By Microdose NewsDesk

Industry

11 Jul 2023

Intiem: Using AI to Innovate Sexual Wellness

There’s a new generation of companies attempting to integrate AI and wellness....

By Microdose NewsDesk

Industry

27 Jun 2023

PharmaTher Initiates Filing of Abbreviated New Drug Application to the FDA

PharmaTher Initiates Filing of Abbreviated New Drug Application for KETARX™ (racemic ketamine) to the FDA...

By Microdose NewsDesk

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

23 Jun 2023

Mindset Pharma Receives Approval for Phase II Depression Trial

Mindset Pharma has been granted approval to start a Phase 2 trial for Major Depressive Disorder, using their lead drug candidate MSP-1014...

By Microdose NewsDesk

Breaking News, Industry

22 Jun 2023

MindMed Survives Takeover Attempt: Shareholders Reject FCM Board Candidates

MindMed shareholders have voted to elect all 6 of the company’s proposed board members — rejecting the candidates from activist investors....

By Jason Najum

Industry

15 Jun 2023

Chacruna Publishes Article Challenging DEA Ayahuasca Report

The Chacruna Institute has published an article in the peer-reviewed Journal of Psychedelic Studies contesting the DEA’s report on ayahuasca...

By Microdose NewsDesk

Industry

7 Jun 2023

Psychedelics in Dubai: Therapeutic Role of Psychedelics Explored at Conference in the Arab Region

This academic event, set to take place on June 10th in Dubai, UAE, marks the first-ever conference in the region with dedicated programming exploring the field of psychedelic-assisted therapies....

By Microdose NewsDesk

Industry

2 Jun 2023

Terran Biosciences Announces Licensing Deal with Pierre Fabre for Idazoxan; Completes Development Milestones

Terran Biosciences announces exclusive licensing deal with Pierre Fabre for idazoxan; Terran completes key development milestones...

By Microdose NewsDesk

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result